...
首页> 外文期刊>Bio-medical materials and engineering >Preparation of self-assembled nanoparticles of chitosan oligosaccharide-graftpolycaprolactone as a carrier of bovine serum albumin drug
【24h】

Preparation of self-assembled nanoparticles of chitosan oligosaccharide-graftpolycaprolactone as a carrier of bovine serum albumin drug

机译:牛血清白蛋白药物载体壳聚糖寡糖-接枝聚己内酯自组装纳米粒子的制备

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chitosan oligosaccharides graft polycaprolactone copolymer (PHCSO-g-PCL) has been synthesized via initiating the polymerization of -caprolactone (CL) monomer through an amino group protection route using phthaloyl chitosan oligosaccharide (PHCSO) as intermediate. The grafting reaction was carried out in Pyridine at 120C with the hydroxyl group of the chitosan oligosaccharide (CSO) as initiator and the tin 2-ethylhexanoate (Sn (Oct)2) as catalyst. The PHCSO-g-PCL nanoparticles with and without bovine serum albumin (BSA) drug were prepared through the self-assembled approach in Dimethylformamide (DMF) organic solvents. PHCSO-PCL copolymer was investigated by Fourier transform infrared spectroscopy (FTIR), 1H NMR spectrum and scanning electron microscopy (SEM). The physicochemical properties of the hydrophobized PHCSO-g-PCL nanoparticles were characterized by fluorescence spectroscopy and dynamic light scattering (DLS). The results of DLS showed that the hydrodynamic diameters and particle size distribution with various concentrations of PHCSO-g-PCL nanoparticles were from 69.82 nm to 195.9 nm with a narrow polydispersity factor of 0.212 to 0.172. The results of DLS also showed that the hydrodynamic diameters and particle size distribution of PHCSO-g-PCL (5 mg/ml) nanoparticles without and with BSA drug (0.4 mg/ml) were from 168.44 nm to 200.7 nm. The polydispersity factor was from 0.119 to 0.159..
机译:壳聚糖低聚糖接枝聚己内酯共聚物(PHCSO-g-PCL)是通过使用邻苯二甲酰壳聚糖低聚糖(PHCSO)作为中间体通过氨基保护途径引发-己内酯(CL)单体的聚合反应而合成的。在壳聚糖低聚糖(CSO)的羟基作为引发剂和2-乙基己酸锡(Sn(Oct)2)作为催化剂的条件下,在120℃的吡啶中进行接枝反应。通过在二甲基甲酰胺(DMF)有机溶剂中的自组装方法,制备了带有和不带有牛血清白蛋白(BSA)药物的PHCSO-g-PCL纳米粒子。通过傅立叶变换红外光谱(FTIR),1H NMR光谱和扫描电子显微镜(SEM)研究了PHCSO-PCL共聚物。疏水化的PHCSO-g-PCL纳米粒子的理化性质通过荧光光谱和动态光散射(DLS)进行了表征。 DLS的结果表明,各种浓度的PHCSO-g-PCL纳米颗粒的流体力学直径和粒径分布为69.82nm至195.9nm,窄的多分散系数为0.212至0.172。 DLS的结果还显示,没有和有BSA药物(0.4mg / ml)的PHCSO-g-PCL(5mg / ml)纳米颗粒的流体动力学直径和粒径分布为168.44nm至200.7nm。多分散系数为0.119至0.159。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号